Mycophenolate Interruption Restores Anti-SARS-CoV-2 Vaccine Immunogenicity in Unresponsive Liver Transplant Recipients.

Pierluigi ToniuttoAnnarosa CussighSara CmetMartina Fabris Francesco CurcioDavide BitettoEzio FornasiereElisa FumoloEdmondo Falleti

Published in: Vaccines (2023)

Suspending MMF prior to the fourth dose of the anti-SARS-CoV-2 mRNA vaccine seems feasible and safe. This procedure could restore vaccine-induced immunogenicity in a large portion of previously nonresponsive LT recipients.

Keyphrases

sars cov
respiratory syndrome coronavirus
minimally invasive
diabetic rats
oxidative stress
coronavirus disease